|
Dobutamine HclDrug - Dobutamine Hcl The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Dobutamine Hydrochloride
Strength -
EQ 12.5MG BASE/ML
Applicant -
ASTRAZENECA
New Drug Application (NDA) Number -
074098
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Feb 21, 1995
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Astrazeneca Lp
Dobutamine Hcl
Depakote Cp Eq 250mg Base Tablet, Delayed Release; Oral
Depakote Cp Eq 500mg Base Tablet, Delayed Release; Oral Depakote Er Eq 250mg Valproic Acid Tablet, Extended Release; Oral Depakote Er Eq 500mg Valproic Acid Tablet, Extended Release; Oral Dobutamine Hcl Eq 12.5mg Base/ml Injectable; Injection Disulfiram 500mg Tablet; Oral Depakote Eq 125mg Valproic Acid Capsule, Delayed Rel Pellets; Oral Depakote Eq 125mg Valproic Acid Tablet, Delayed Release; Oral Depakote Eq 250mg Valproic Acid Tablet, Delayed Release; Oral Depakote Eq 500mg Valproic Acid Tablet, Delayed Release; Oral NewDrugInformation |